Stocks
Sarepta Therapeutics (SRPT) Net margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| Net margin, % | ? | -59.7% | -75.4% | -43.1% | 12.4% | -32.5% | 2.98% | ||
| Changes by years, y/y, % | +43pp | -16pp | +32pp | +55pp | -45pp | -40% | |||
Sarepta Therapeutics. Net margin, %
Sarepta Therapeutics. Net margin, changes, pp
Sarepta Therapeutics (SRPT) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| Net margin, % | ? | 32.2% | -45.1% | -63.9% | 45.3% | -1.22% | 2.98% | |
| Changes by years, y/y, % | +30pp | -52pp | -88pp | +105pp | -33pp | |||
| Changes by quarters, q/q, % | +92pp | -77pp | -19pp | +109pp | -47pp | |||
